Free Trial

Biotricity Q3 2024 Earnings Report

Biotricity logo
$0.35 0.00 (-0.03%)
As of 03:55 PM Eastern

Biotricity EPS Results

Actual EPS
-$0.34
Consensus EPS
-$0.41
Beat/Miss
Beat by +$0.07
One Year Ago EPS
N/A

Biotricity Revenue Results

Actual Revenue
$2.97 million
Expected Revenue
$3.00 million
Beat/Miss
Missed by -$30.00 thousand
YoY Revenue Growth
N/A

Biotricity Announcement Details

Quarter
Q3 2024
Time
N/A

Biotricity Earnings Headlines

7 Explosive Stocks Every Investor Needs for 2025
What if you could identify the next big stocks before everyone else? Our exclusive report, "7 Stocks to 10x: High-Growth Stocks Ready to Buy for 2025," highlights the best investment opportunities you won’t want to miss.
Biotricity Inc BTCY
See More Biotricity Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biotricity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biotricity and other key companies, straight to your email.

About Biotricity

Biotricity (OTCMKTS:BTCY), a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

View Biotricity Profile

More Earnings Resources from MarketBeat